Literature DB >> 15178501

Radiological evidence of nonalcoholic fatty liver disease in familial combined hyperlipidemia.

Tjerk W A de Bruin1, Anna M Georgieva, Martijn C G J Brouwers, Martijn V Heitink, Carla J H van der Kallen, Marleen M J van Greevenbroek.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15178501     DOI： 10.1016/j.amjmed.2003.12.031

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  6 in total

1.  Association of stearoyl-CoA desaturase 1 activity with familial combined hyperlipidemia.

Authors:  Rebecca Mar-Heyming; Makoto Miyazaki; Daphna Weissglas-Volkov; Nicholas A Kolaitis; Narimaan Sadaat; Christopher Plaisier; Päivi Pajukanta; Rita M Cantor; Tjerk W A de Bruin; James M Ntambi; Aldons J Lusis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03-13       Impact factor: 8.311

2.  Secondary causes of nonalcoholic fatty liver disease.

Authors:  Jacob M Kneeman; Joseph Misdraji; Kathleen E Corey
Journal:  Therap Adv Gastroenterol       Date:  2012-05       Impact factor: 4.409

Review 3.  Non-alcoholic fatty liver disease in lean individuals.

Authors:  Somaya Albhaisi; Abhijit Chowdhury; Arun J Sanyal
Journal:  JHEP Rep       Date:  2019-08-30

4.  Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia.

Authors:  Giuseppe Mandraffino; Carmela Morace; Maria Stella Franzè; Veronica Nassisi; Davide Sinicropi; Maria Cinquegrani; Carlo Saitta; Riccardo Scoglio; Sebastiano Marino; Alessandra Belvedere; Valentina Cairo; Alberto Lo Gullo; Michele Scuruchi; Giovanni Raimondo; Giovanni Squadrito
Journal:  Biomedicines       Date:  2022-07-22

Review 5.  Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date.

Authors:  Antonio Gaddi; A F G Cicero; F O Odoo; A A Poli; R Paoletti
Journal:  Vasc Health Risk Manag       Date:  2007

6.  Zebrafish mutants provide insights into Apolipoprotein B functions during embryonic development and pathological conditions.

Authors:  Hanoch Templehof; Noga Moshe; Inbal Avraham-Davidi; Karina Yaniv
Journal:  JCI Insight       Date:  2021-07-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.